Evidence map›Paper›PMID 19155491›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection.

Matthew D Eberly, Muhamuda Kader, Wail Hassan, Kenneth A Rogers, Jianzhong Zhou, Yvonne M Mueller, Mary J Mattapallil, Michael Piatak, Jeffrey D Lifson, Peter D Katsikis and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. CD16Blood advances · 2018
    Article
  16. IL-15 regulates susceptibility of CD4Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Matthew D EberlyUniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Muhamuda Kader
Wail Hassan
Kenneth A Rogers
Jianzhong Zhou
Yvonne M Mueller
Mary J Mattapallil
Michael Piatak
Jeffrey D Lifson
Peter D Katsikis
Mario Roederer
Francois Villinger
Joseph J Mattapallil
Uniformed Services University of the Health Sciences · USEmory University · USDrexel University · USFrederick National Laboratory for Cancer Research · USNational Institutes of Health · US

Funding

T Cell Dynamics In SIV-infected MacaquesZIAAI005019 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ROEDERER, MARIO · 2009 to 2014
$3.5M
Mucosal immunity and rectal challengeR01DE019397 · NIDCR · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MATTAPALLIL, JOSEPH JOHN · 2009 to 2011
$2.4M
IL-15 treatment of SIV-infected non-human primatesR01AI062437 · NIAID · DREXEL UNIVERSITY · PI KATSIKIS, PETER D · 2005 to 2008
$2.1M
Mucosal Epithelium and Long-Term Anti-Retroviral TherapyR21DE018339 · NIDCR · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MATTAPALLIL, JOSEPH JOHN · 2007 to 2008
$673k
CD4 T cells and anti-viral control in SIV infectionK22AI071812 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI MATTAPALLIL, JOSEPH JOHN · 2007 to 2008
$270k
NCI NIH HHS N01-CO-124000NIAID NIH HHS K22 AI071812NIAID NIH HHS K22 AI07812NIAID NIH HHS R01 AI062437NIDCR NIH HHS R01 DE019397NIDCR NIH HHS R21 DE018339
6 · The paper itself

Abstract

Acute SIV infection is characterized by explosive infection of memory CD4 T cells in peripheral and mucosal tissues. Interestingly, relatively few memory CD4 T cells are infected until as late as days 7-8 after challenge. However, by day 10 postinfection, most of the memory CD4 T cells are infected and carry viral DNA. The rapidity with which infection expands within 2-3 days to encompass virtually the entire memory CD4 T cell compartment suggests significant alterations in the susceptibility of memory CD4 T cells to infection during this period. The mechanism(s) underlying this increased permissiveness to infection is not known. In this study, we show that IL-15 secretion significantly correlates with the up-regulated expression of CD4 on memory CD4 T cells that is associated with increased permissiveness to SIV infection. Activation and proliferation of memory CD8, but not memory CD4 T cells, preceded the amplification of viral infection. Although memory CD4 T cells did not express normal activation markers, they displayed a significant up-regulation in the density of CD4 but not CCR5 expression between days 7 and 10 postinfection that correlated with increased plasma IL-15 levels and infection in these cells. Culture of purified CD4 T cells with IL-15 and/or SIV was associated with a significant increase in the expression of CD4 and infection of these sorted cells. Our results demonstrate that IL-15 contributes to the increased susceptibility of memory CD4 T cells to SIV during the early phase of acute SIV infection.

Indexed as

Immunologic MemoryAcute DiseaseAnimalsCD4-Positive T-LymphocytesCell ProliferationCells, CulturedDisease SusceptibilityInterleukin-15Interleukin-15 Receptor alpha SubunitLongitudinal StudiesLymphocyte ActivationMacaca mulattaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusUp-RegulationVirus ReplicationInterleukin-15Interleukin-15 Receptor alpha Subunit

Identifiers

PMID19155491
PMCPMC2662754
OpenAlexW1888844556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.